Get started
Author

Marilina García‐Aranda

Observed names: García‐Aranda Marilina, M. Garcia-Aranda, M. García-Aranda, Maria García-Aranda, Marilina Garcia-Aranda, Marilina García, Marilina García Aranda, Marilina García-Aranda
Institutions: Instituto de Salud Carlos III, Hospital Costa del Sol, Andalusian Centre for Nanomedicine and Biotechnology, Instituto de Investigación Biomédica de Málaga, Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Universidad de Málaga
Observed institutions: Instituto de Salud Carlos III, Hospital Costa del Sol, Andalusian Centre for Nanomedicine and Biotechnology, Hospital Universitario Virgen del Rocío, Agencia Sanitaria Costa del Sol, Instituto de Investigación Biomédica de Málaga, Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Universidad de Málaga
ORCID: 0000-0003-3759-4044
Observed ORCID: 0000-0003-3759-4044
OpenAlex ID: A5049752008
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
2020 · Elisabeth Pérez-Ruiz, Ignacio Melero, et al. · Drug Resistance Updates · 203
PDF
Immunotherapy: A Challenge of Breast Cancer Treatment
2019 · Marilina García-Aranda, Maximino Redondo · Cancers · 185
PDF
Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
2018 · Marilina García-Aranda, Elisabet Pérez-Ruiz, et al. · International Journal of Molecular Sciences · 147
Protein Kinase Targets in Breast Cancer
2017 · Marilina García-Aranda, Maximino Redondo · International Journal of Molecular Sciences · 78
Targeting Receptor Kinases in Colorectal Cancer
2019 · Marilina García-Aranda, Maximino Redondo · Cancers · 75
PDF
Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction
2021 · Javier Oliver, Marilina Garcia-Aranda, et al. · Seminars in Cancer Biology · 46
PDF
Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy
2019 · Marilina García-Aranda, Maximino Redondo · International Journal of Molecular Sciences · 44
Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance
2022 · Marilina García-Aranda, Teresa Téllez, et al. · Cancers · 42
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity
2007 · Maximino Redondo, Teresa Téllez, et al. · Breast Cancer Research · 41
PDF
Clusterin inhibition mediates sensitivity to chemotherapy and radiotherapy in human cancer
2017 · Marilina García-Aranda, Teresa Téllez, et al. · Anti-Cancer Drugs · 33
Regulation of Clusterin Gene Expression
2018 · Marilina Garcia-Aranda, Alfonso Serrano, et al. · Current Protein and Peptide Science · 30
Biomarker Identification through Proteomics in Colorectal Cancer
2024 · Desirée Martín-García, Marilina García-Aranda, et al. · International Journal of Molecular Sciences · 29
PDF
The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target
2016 · T. Tellez, M. Garcia-Aranda, et al. · Current Medicinal Chemistry · 26
Unlocking New Avenues in Breast Cancer Treatment: The Synergy of Kinase Inhibitors and Immunotherapy
2023 · María José Bravo, Antonio Manuel Burgos-Molina, et al. · Cancers · 12
PDF
Therapeutic Potential of Clusterin Inhibition in Human Cancer
2024 · Desirée Martín-García, Marilina García-Aranda, et al. · Cells · 11
PDF
The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer
2023 · Desirée Martín-García, Teresa Téllez, et al. · Current Medicinal Chemistry · 9
PDF
Calcium Homeostasis in the Development of Resistant Breast Tumors
2023 · Desirée Martin-García, Teresa Téllez, et al. · Cancers · 8
PDF
Clusterin Expression in Colorectal Carcinomas
2023 · Teresa Téllez, Desirée Martin-García, et al. · International Journal of Molecular Sciences · 7
PDF
Analysis of the association between adverse events and outcome in patients receiving a programmed death protein-1 or programmed death ligand-1 antibody
2020 · Marilina García-Aranda, Maximino Redondo · Chinese Clinical Oncology · 7
PDF
Evaluation of the EasyNAT SARS-CoV-2 assay PCR test for the diagnosis of SARS-CoV-2 infection
2024 · Fernando Fernández-Sánchez, Elena Martín-Bautista, et al. · Journal of Virological Methods · 6
Free Thyroxine Determination in the Emergency Department Is a Predictor of Acute Pancreatitis Evolution
2018 · Gonzalo Callejón, Emilia Redondo, et al. · Pancreas · 6
Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study
2025 · Desirée Martín-García, Marilina García-Aranda, et al. · European Journal of Surgical Oncology · 5
PDF
Clusterin expression and distribution in spermatozoa as predictor of male fertility
2024 · María Hernández‐Herrador, García‐Aranda Marilina, et al. · Molecular Reproduction and Development · 4
PDF
Downregulation of clusterin mediates sensitivity to protein kinase inhibitors in breast cancer cells
2014 · Maximino Redondo, Marilina García-Aranda, et al. · Anti-Cancer Drugs · 4
Long-term prognostic value of apoptotic index in colorectal cancer: a 5-year multicentre cohort study
2025 · Marilina García-Aranda, Cristina Abitei, et al. · Pathology · 3
Works count: 40
Citation count: 1,082
H-index: 13
I10-index: 15
Year
Topic
Type